Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227337 · ClinicalTrials.gov registry record · NA
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
A NA study of Depression and Post Traumatic Stress Disorder, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 676
- Enrollment target
- 1
- Study location
NCT07227337: Recruiting NA study of Depression and Post Traumatic Stress Disorder, sponsored by Johns Hopkins University.
NCT07227337 is a NA study of Depression and Post Traumatic Stress Disorder that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 676 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227337, a NA study of Depression and Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 676 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate a trauma informed digital multicomponent intervention design to improve health and safety outcomes for women with lifetime exposures to violence and co-occurring PTSD and/or depression symptoms
Primary Outcome
The Perceived Stress Scale-10 (PSS-10) is a 10-item questionnaire that measures the degree to which situations in one's life are appraised as stressful. Total scores range from 0 to 40, with higher scores indicating higher levels of perceived stress.
Conditions Studied
Interventions
- BEHAVIORAL BSHAPE
- OTHER Control (general wellness)
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 676 participants |
| Start Date | 2025-11-05 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07227337 shows while recruiting
NCT07227337 is an interventional study that assigns participants to a tested intervention. The registered 676 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 679 other Depression trials with a reported enrollment target (14% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which BSHAPE is the first listed.
NCT07227337 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT07227337 about?
NCT07227337 is a clinical study titled "Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study". The purpose of the study is to evaluate a trauma informed digital multicomponent intervention design to improve health and safety outcomes for women with lifetime exposures to violence and co-occurring PTSD and/or depression symptoms
What is the current status of trial NCT07227337?
This trial is currently recruiting. It is a NA study. The enrollment target is 676 participants. The study started on 2025-11-05. Estimated completion is 2028-12-31.
What conditions does trial NCT07227337 study?
This clinical trial studies the following conditions: Depression, Post Traumatic Stress Disorder, Violence.
What interventions are being tested in trial NCT07227337?
The interventions under investigation include: BSHAPE (BEHAVIORAL), Control (general wellness) (OTHER).
Who is sponsoring clinical trial NCT07227337?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227337 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07227337's enrollment target sits among peer trials
676 59th of 679 higher than 620 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04788277 · 675 participants
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
- NCT05356234 · 675 participants · NA
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
- NCT06070870 · 675 participants · NA
Health Education Approach to Lung Screening
- NCT06357533 · 675 participants · Phase 3
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy